HIV Pre-Exposure Prophylaxis in Transgender Women: A Subgroup Analysis of the iPrEx Trial
November 2015
in “
The Lancet HIV
”
Studysummary This study observed that while PrEP was effective among transgender women if taken, adherence was low, especially among those at higher risk.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer